{"@context":{"@vocab":"https://schema.org/"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/fda/warning-letters/check?name=Fancystage%20Unipessoal%2C%20LDA","name":"Fancystage Unipessoal, LDA","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters","generated_at":"2026-10-03T21:07:25.097Z"},"count":1,"matches":[{"id":"6f047297ffb47ef2","posted_date":"2023-08-08","letter_issue_date":"2023-08-03","company_name":"Fancystage Unipessoal, LDA","issuing_office":"Center for Drug Evaluation and Research | CDER","subject":"CGMP/Finished Pharmaceuticals/Adulterated","canonical_url":"https://api.morvs.ai/fda-warning/6f047297ffb47ef2"}]}